19-11113300-C-T

Variant summary

Our verdict is Uncertain significance.
0 Uncertain · Cold
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 0 classification points (ACGS-UK Somatic Oncogenicity v2025).

The NR_106946.1(MIR6886):n.-174C>T variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. Note: NR_106946.1 is not a MANE Select or MANE Plus Clinical transcript for MIR6886; the reported annotation may differ from that of the MANE-designated reference transcript for this gene. The variant allele was found at a cumulative frequency of 0.0000105 (AC=17) in the gnomAD database across 1,613,302 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000207. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). The variant has been observed in cBioPortal in 2 samples across 2 studies and 1 cancer type; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 29)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

MIR6886
NR_106946.1 upstream_gene

Scores

3

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 3.32

Publications

0 publications found
Variant links:
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
LDLR Gene-Disease associations (from GenCC):
  • hypercholesterolemia, familial, 1
    Inheritance: SD, AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Natera
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
MIR6886 (HGNC:50121): (microRNA 6886) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NR_106946.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 0 points.

No applied criteria
Uncheck "Show applied only" above to review all 20 criteria.

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NR_106946.1. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

LDLR NM_000527.5
MANE Select
HGVSc / HGVSpc.1209C>Tp.Phe403Phe
Exon rankExon 9 of 18
synonymous
Prot: NP_000518.1UniProt: P01130-1
LDLR NM_001195798.2
HGVSc / HGVSpc.1209C>Tp.Phe403Phe
Exon rankExon 9 of 18
synonymous
Prot: NP_001182727.1UniProt: P01130-5
LDLR NM_001195799.2
HGVSc / HGVSpc.1086C>Tp.Phe362Phe
Exon rankExon 8 of 17
synonymous
Prot: NP_001182728.1UniProt: P01130-4
LDLR NM_001195800.2
HGVSc / HGVSpc.705C>Tp.Phe235Phe
Exon rankExon 7 of 16
synonymous
Prot: NP_001182729.1UniProt: P01130-3
LDLR NM_001195803.2
HGVSc / HGVSpc.828C>Tp.Phe276Phe
Exon rankExon 8 of 16
synonymous
Prot: NP_001182732.1UniProt: P01130-2
MIR6886 NR_106946.1
HGVSc / HGVSpn.-174C>T
Exon rankN/A
upstream_gene
Prot:

Ensembl Transcripts

LDLR ENST00000558518.6
TSL:1MANE Select
HGVSc / HGVSpc.1209C>Tp.Phe403Phe
Exon rankExon 9 of 18
synonymous
Prot: ENSP00000454071.1UniProt: P01130-1
LDLR ENST00000252444.10
TSL:1
HGVSc / HGVSpc.1467C>Tp.Phe489Phe
Exon rankExon 9 of 18
synonymous
Prot: ENSP00000252444.6UniProt: J3KMZ9
LDLR ENST00000558013.5
TSL:1
HGVSc / HGVSpc.1209C>Tp.Phe403Phe
Exon rankExon 9 of 18
synonymous
Prot: ENSP00000453346.1UniProt: P01130-5

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.00000657
AC:1
Hom:0
AN:152118
Cov:29
GnomAD2 exomes
AF: 0.0000239
AC:6
AN:250952
GnomAD4 exome
AF: 0.0000110
AC:16
Hom:0
AN:1461184
Cov:33
GnomAD4 genome
AF: 0.00000657
AC:1
Hom:0
AN:152118
Cov:29
TOPMed (Bravo)
AF: 0.00000378
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:0
AN:13470
Showing 6 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.0000211 294920 0.0000412 7169724
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Familial hypercholesterolemia (1)
-
-
1
Hypercholesterolemia, familial, 1 (1)

Computational Scores

AlphaGenome AVI
Uncertain13
BayesDel_noAF
Benign-0.50
CADD
Benign8.7
DANN
Benign0.84
GPN-Star LLR
N/A-1.8
GPN-Star score
N/A1.8
PhyloP100
Benign3.3
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.7
Showing 9 of 9 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.040
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.